SLC22A5 and systemic primary carnitine deficiency disease: In 2015, the Health Council of the Netherlands advised to include carnitine deficiency in the NBS panel, because of the health benefits for newborns [7], however, thus far, the decision to officially include OCTN2 deficiency in the NBS has not yet been made.